Literature DB >> 28779286

Where Does Inflammation Fit?

Luigi M Biasucci1, Giulio La Rosa2, Daniela Pedicino2, Alessia D'Aiello2, Mattia Galli2, Giovanna Liuzzo2.   

Abstract

PURPOSE OF REVIEW: This review focuses on the complex relationship between inflammation and the onset of acute coronary syndrome and heart failure. RECENT
FINDINGS: In the last few years, two important lines of research brought new and essential information to light in the pathogenesis of acute coronary syndrome: a) the understanding of the immune mediate mechanisms of inflammation in Ischemic Heart Disease (IHD) and b) evidence that the inflammatory mechanisms associated with atherosclerosis and its complications can be modulated by anti-inflammatory molecules. A large amount of data also suggests that inflammation is a major component in the development and exacerbation of heart failure (HF), in a symbiotic relationship. In particular, recent evidence underlies peculiar aspects of the phenomenon: oxidative stress and autophagy; DAMPS and TLR-4 signaling activation; different macrophages lineage and the contribution of NLRP-3 inflammasome; adaptive immune system. A possible explanation that could unify the pathogenic mechanism of these different conditions is the rising evidence that increased bowel permeability may allow translation of gut microbioma product into the circulation. These findings clearly establish the role of inflammation as the great trigger for two of the major cardiovascular causes of death and morbidity. Further studies are needed, to better clarify the issue and to define more targeted approaches to reduce pathological inflammation while preserving the physiological one.

Entities:  

Keywords:  Acute coronary syndrome; Gut micrombioma; Heart failure; Immune system; Inflammation

Mesh:

Substances:

Year:  2017        PMID: 28779286     DOI: 10.1007/s11886-017-0896-0

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  77 in total

1.  IRAK-M is a negative regulator of Toll-like receptor signaling.

Authors:  Koichi Kobayashi; Lorraine D Hernandez; Jorge E Galán; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

2.  Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

Authors:  F Haverkate; S G Thompson; S D Pyke; J R Gallimore; M B Pepys
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

3.  Altered CD31 expression and activity in helper T cells of acute coronary syndrome patients.

Authors:  Davide Flego; Anna Severino; Francesco Trotta; Marco Previtero; Sara Ucci; Chiara Zara; Daniela Pedicino; Gianluca Massaro; Luigi M Biasucci; Giovanna Liuzzo; Filippo Crea
Journal:  Basic Res Cardiol       Date:  2014-10-26       Impact factor: 17.165

4.  Interleukin-17 in atherosclerosis and cardiovascular disease: the good, the bad, and the unknown.

Authors:  Giovanna Liuzzo; Francesco Trotta; Daniela Pedicino
Journal:  Eur Heart J       Date:  2012-11-23       Impact factor: 29.983

5.  Identification of unique adaptive immune system signature in acute coronary syndromes.

Authors:  Giovanna Liuzzo; Rocco A Montone; Mario Gabriele; Daniela Pedicino; Ada F Giglio; Francesco Trotta; Vincenzo A Galiffa; Marco Previtero; Anna Severino; Luigi M Biasucci; Filippo Crea
Journal:  Int J Cardiol       Date:  2013-02-05       Impact factor: 4.164

Review 6.  NLRP3 inflammasome as a novel player in myocardial infarction.

Authors:  Masafumi Takahashi
Journal:  Int Heart J       Date:  2014-03-14       Impact factor: 1.862

7.  Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy.

Authors:  G Christian Baldeviano; Jobert G Barin; Monica V Talor; Sachin Srinivasan; Djahida Bedja; Dongfeng Zheng; Kathleen Gabrielson; Yoichiro Iwakura; Noel R Rose; Daniela Cihakova
Journal:  Circ Res       Date:  2010-04-08       Impact factor: 17.367

Review 8.  Update on acute coronary syndromes: the pathologists' view.

Authors:  Erling Falk; Masataka Nakano; Jacob Fog Bentzon; Aloke V Finn; Renu Virmani
Journal:  Eur Heart J       Date:  2012-12-13       Impact factor: 29.983

9.  Functional effects of a restrictive-cardiomyopathy-linked cardiac troponin I mutation (R145W) in transgenic mice.

Authors:  Yuhui Wen; Yuanyuan Xu; Yingcai Wang; Jose Renato Pinto; James D Potter; W Glenn L Kerrick
Journal:  J Mol Biol       Date:  2009-08-03       Impact factor: 5.469

10.  Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

Authors:  Douglas L Mann; John J V McMurray; Milton Packer; Karl Swedberg; Jeffrey S Borer; Wilson S Colucci; Jacques Djian; Helmut Drexler; Arthur Feldman; Lars Kober; Henry Krum; Peter Liu; Markku Nieminen; Luigi Tavazzi; Dirk Jan van Veldhuisen; Anders Waldenstrom; Marshelle Warren; Arne Westheim; Faiez Zannad; Thomas Fleming
Journal:  Circulation       Date:  2004-03-15       Impact factor: 29.690

View more
  8 in total

1.  NADPH Oxidase 4 Regulates Inflammation in Ischemic Heart Failure: Role of Soluble Epoxide Hydrolase.

Authors:  Mark D Stevenson; Chandrika Canugovi; Aleksandr E Vendrov; Takayuki Hayami; Dawn E Bowles; Karl-Heinz Krause; Nageswara R Madamanchi; Marschall S Runge
Journal:  Antioxid Redox Signal       Date:  2018-12-28       Impact factor: 8.401

2.  Immunity, Inflammation and Heart Failure: Their Role on Cardiac Function and Iron Status.

Authors:  Maria Perticone; Roberta Zito; Sofia Miceli; Angelina Pinto; Edoardo Suraci; Marta Greco; Simona Gigliotti; Marta Letizia Hribal; Salvatore Corrao; Giorgio Sesti; Francesco Perticone
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

Review 3.  Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases.

Authors:  Augusto Bleve; Francesca Motta; Barbara Durante; Chiara Pandolfo; Carlo Selmi; Antonio Sica
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-15       Impact factor: 10.817

Review 4.  Molecular basis of acute coronary syndrome.

Authors:  Natalya Balashkevich; Maxut Kazymov; Marat Syzdykbayev; Aima Adylova
Journal:  J Res Med Sci       Date:  2022-05-30       Impact factor: 1.985

5.  Incessant pericarditis following the second dose of SARS-CoV-2 mRNA vaccine successfully treated with anakinra: a case report.

Authors:  C Conte; G Princi; D D'Amario; T Sanna; D Pedicino; G Liuzzo
Journal:  Eur Heart J Case Rep       Date:  2022-09-13

6.  Combined influence of depressive symptoms and systemic inflammation on all-cause and cardiovascular mortality: evidence for differential effects by gender in the English Longitudinal Study of Ageing.

Authors:  Samantha Lawes; Panayotes Demakakos; Andrew Steptoe; Glyn Lewis; Livia A Carvalho
Journal:  Psychol Med       Date:  2018-09-17       Impact factor: 7.723

Review 7.  The interplay between immunosenescence and age-related diseases.

Authors:  Florencia Barbé-Tuana; Giselle Funchal; Carine Raquel Richter Schmitz; Rafael Moura Maurmann; Moisés E Bauer
Journal:  Semin Immunopathol       Date:  2020-08-03       Impact factor: 9.623

8.  Molecular Hallmarks of Ischemia with Non-Obstructive Coronary Arteries: The "INOCA versus Obstructive CCS" Challenge.

Authors:  Alice Bonanni; Alessia d'Aiello; Daniela Pedicino; Marianna Di Sario; Ramona Vinci; Myriana Ponzo; Pellegrino Ciampi; Denise Lo Curto; Cristina Conte; Francesco Cribari; Francesco Canonico; Giulio Russo; Rocco Antonio Montone; Carlo Trani; Anna Severino; Filippo Crea; Giovanna Liuzzo
Journal:  J Clin Med       Date:  2022-03-19       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.